Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiotoxicity of Cancer Therapy: Mechanisms and Predictors

NCT01173341 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT01173341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01173341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiotoxicity of Cancer Therapy: Mechanisms and Predictors
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 31, 2010
Completion date
April 30, 2037
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer